Melatonin supplementation as an adjuvant therapy in neonatal respiratory distress syndrome

Phase 1

Active, not recruiting

• Conditions: respiratory distress syndrome; neonates; respiratory; distress; syndrome

• Registration Number: TCTR20200326001
• Lead Sponsor: mohamed shawky elfarargy

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2017-12-27
• Study Start: 2020-03-26
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Active, not recruiting
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

neonates
respiratory distress syndrome

Exclusion Criteria

age more than 28 days

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
decreased Malondialdehyde (MDA) and increased Superoxide Dismutase (SOD) 10 months ELISA

Secondary Outcome Measures

Name	Time	Method
decreased Interleukin-8(IL-8) 12 months ELISA